Results 151 to 160 of about 65,570 (200)
Polypharmacy in Nursing Home in Europe: Results From the SHELTER Study
Journals of Gerontology - Series A Biological Sciences and Medical Sciences, 2012 This study assesses prevalence and patients characteristics related to polypharmacy in a sample of nursing home ...
Graziano Önder +2 more
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Polypharmacy and Deprescribing
JAMA, 2023This JAMA Patient Page describes the problem of polypharmacy and its consequences, and how deprescribing can reduce polypharmacy.
Sarah E, Vordenberg +2 more
openaire +2 more sources
Current Opinion in Psychiatry, 2010
Although most guidelines recommend monotherapy in schizophrenia, the combined application of multiple psychotropic agents is very common, especially in treatment-refractory cases. We review the empirical basis supporting these attempts and their relevance for clinical practice.Polypharmacy intends to address different aspects of treatment resistance ...
M, Zink +2 more
openaire +3 more sources
Although most guidelines recommend monotherapy in schizophrenia, the combined application of multiple psychotropic agents is very common, especially in treatment-refractory cases. We review the empirical basis supporting these attempts and their relevance for clinical practice.Polypharmacy intends to address different aspects of treatment resistance ...
M, Zink +2 more
openaire +3 more sources
Clinics in Geriatric Medicine, 2022
Polypharmacy, defined as taking five medications or more, is a common geriatric syndrome. It is especially prevalent in older adults with cancer. For older patients with breast, lung, prostate, and colorectal cancer and chronic lymphocytic leukemia, polypharmacy has numerous adverse effects, including interactions with medications prescribed for other ...
Justin J, Cheng +4 more
openaire +2 more sources
Polypharmacy, defined as taking five medications or more, is a common geriatric syndrome. It is especially prevalent in older adults with cancer. For older patients with breast, lung, prostate, and colorectal cancer and chronic lymphocytic leukemia, polypharmacy has numerous adverse effects, including interactions with medications prescribed for other ...
Justin J, Cheng +4 more
openaire +2 more sources
Current Opinion in Clinical Nutrition and Metabolic Care, 2013
Malnutrition and polypharmacy increase with age and polymorbidity and their relationship is based on a number of mechanisms. The occurrence of malnutrition in both in-patients and out-patients and its dependence on polymorbidity and age are well known, but the interrelation of polypharmacy and malnutrition has been far less investigated.
Zdenek, Zadak +3 more
openaire +2 more sources
Malnutrition and polypharmacy increase with age and polymorbidity and their relationship is based on a number of mechanisms. The occurrence of malnutrition in both in-patients and out-patients and its dependence on polymorbidity and age are well known, but the interrelation of polypharmacy and malnutrition has been far less investigated.
Zdenek, Zadak +3 more
openaire +2 more sources
Zeitschrift für Gerontologie und Geriatrie, 2012
Polypharmacy as well as urinary incontinence are common geriatric problems. Possible adverse drug effects remain a matter of concern in geriatric medicine and must be considered in urinary incontinence. The occurrence or aggravation of lower urinary tract symptoms might be caused by medication, especially when the symptom is newly diagnosed.
H, Talasz, M, Lechleitner
openaire +2 more sources
Polypharmacy as well as urinary incontinence are common geriatric problems. Possible adverse drug effects remain a matter of concern in geriatric medicine and must be considered in urinary incontinence. The occurrence or aggravation of lower urinary tract symptoms might be caused by medication, especially when the symptom is newly diagnosed.
H, Talasz, M, Lechleitner
openaire +2 more sources
Zeitschrift für Gerontologie und Geriatrie, 2012
Osteoporosis is very common in elderly patients. Despite the severe health-related consequences for individual patients and the socioeconomic costs caused by osteoporotic fractures, treatment rates are still low. Due to drug interactions and patient compliance, polypharmacy is often mentioned as a reason for undertreatment.
M, Gosch +3 more
openaire +2 more sources
Osteoporosis is very common in elderly patients. Despite the severe health-related consequences for individual patients and the socioeconomic costs caused by osteoporotic fractures, treatment rates are still low. Due to drug interactions and patient compliance, polypharmacy is often mentioned as a reason for undertreatment.
M, Gosch +3 more
openaire +2 more sources
Polypharmacy and psychotropic polypharmacy in adults with intellectual disability: a cross‐sectional total population study [PDF]
Journal of Intellectual Disability Research, 2020 Background Adults with intellectual disability (ID) are prescribed high levels of medication, with polypharmacy and psychotropic polypharmacy common. However, reported rates vary between studies, and there has been an over‐reliance on obtaining data from
Martin Mcmahon +2 more
exaly +2 more sources
American Journal of Nursing, 1996
gency department at 7 PM on the advice of her physician after she complained of chest pain and difficulty breathing. The physician called ahead to notify the ED and to request a cardiology consult. Six months ago, Ms. Bethel had an MI and underwent coronary angioplasty with insertion of a stent. At the ED, she characterized her epigastric pain as worse
L L, Lilley, R, Guanci
openaire +2 more sources
gency department at 7 PM on the advice of her physician after she complained of chest pain and difficulty breathing. The physician called ahead to notify the ED and to request a cardiology consult. Six months ago, Ms. Bethel had an MI and underwent coronary angioplasty with insertion of a stent. At the ED, she characterized her epigastric pain as worse
L L, Lilley, R, Guanci
openaire +2 more sources
BMJ, 2013
The King’s Fund report discussed by Wise covers much ground, but its focus is blurred and it misses some core points.1 2 It would take years to implement the sensible changes proposed in managing multimorbidity and in prescribing in care homes. But what do the authors think should be done now? They strangely omit the role of the patient. Patients (and
Andrew, Herxheimer, Patricia, McGettigan
openaire +2 more sources
The King’s Fund report discussed by Wise covers much ground, but its focus is blurred and it misses some core points.1 2 It would take years to implement the sensible changes proposed in managing multimorbidity and in prescribing in care homes. But what do the authors think should be done now? They strangely omit the role of the patient. Patients (and
Andrew, Herxheimer, Patricia, McGettigan
openaire +2 more sources